Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough.

Pelleg A, Xu F, Zhuang J, Undem B, Burnstock G.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619877960. doi: 10.1177/1753466619877960.

2.

Adenosine 5'-triphosphate's role in bradycardia and syncope associated with pulmonary embolism.

Pelleg A, Schulman ES, Barnes PJ.

Respir Res. 2018 Jul 28;19(1):142. doi: 10.1186/s12931-018-0848-2. Review.

3.

Electrophysiologic effects of adenosine versus ATP.

Pelleg A.

J Cardiovasc Electrophysiol. 2017 Nov;28(11):E5. doi: 10.1111/jce.13243. Epub 2017 Oct 26. No abstract available.

PMID:
28467653
4.

Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients.

Basoglu OK, Pelleg A, Kharitonov SA, Barnes PJ.

Pulm Pharmacol Ther. 2017 Aug;45:13-18. doi: 10.1016/j.pupt.2017.04.004. Epub 2017 Apr 6.

5.

IgE Receptor-Mediated Histamine Release in Human Lung Mast Cells: Modulation by Purinergic Receptor Ligands.

Nishi H, Pelleg A, Schulman ES.

Ann Clin Lab Sci. 2016 Sep;46(5):463-9.

PMID:
27650611
6.

Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases.

Pelleg A, Schulman ES, Barnes PJ.

Chest. 2016 Oct;150(4):908-915. doi: 10.1016/j.chest.2016.06.045. Epub 2016 Aug 25. Review.

PMID:
27568579
7.

Decisional Capacity in Amyotrophic Lateral Sclerosis.

Khin Khin E, Minor D, Holloway A, Pelleg A.

J Am Acad Psychiatry Law. 2015 Jun;43(2):210-7. Review.

PMID:
26071511
8.

Adenosine 5'-Triphosphate Test in the Management of Patients With Syncope.

Flammang D, Benditt DG, Church TR, Pelleg A.

Am J Ther. 2016 Nov/Dec;23(6):e1347-e1352.

PMID:
25706187
9.

Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD.

Basoglu OK, Barnes PJ, Kharitonov SA, Pelleg A.

Chest. 2015 Aug;148(2):430-435. doi: 10.1378/chest.14-2285.

PMID:
25590209
10.

Cardiac purinergic signalling in health and disease.

Burnstock G, Pelleg A.

Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20. Review.

11.

Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.

Fine JM, Baillargeon AM, Renner DB, Hoerster NS, Tokarev J, Colton S, Pelleg A, Andrews A, Sparley KA, Krogh KM, Frey WH, Hanson LR.

Exp Brain Res. 2012 Jun;219(3):381-90. doi: 10.1007/s00221-012-3101-0. Epub 2012 May 1.

PMID:
22547371
12.

ATPace™: injectable adenosine 5'-triphosphate : Diagnostic and therapeutic indications.

Pelleg A, Kutalek SP, Flammang D, Benditt D.

Purinergic Signal. 2012 Feb;8(Suppl 1):57-60. doi: 10.1007/s11302-011-9268-1. Epub 2011 Nov 6.

13.

The mechanism of the negative chronotropic and dromotropic actions of adenosine 5'-triphosphate in the heart: an update.

Pelleg A, Belhassen B.

J Cardiovasc Pharmacol. 2010 Jul;56(1):106-9. doi: 10.1097/FJC.0b013e3181e0f8b2. Review.

PMID:
20386456
14.

Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Mustafa SJ, Morrison RR, Teng B, Pelleg A.

Handb Exp Pharmacol. 2009;(193):161-88. doi: 10.1007/978-3-540-89615-9_6. Review.

15.

Pacing-induced cardiac gap junction remodeling: modulation of connexin43 phosphorylation state.

Matsushita S, Tran VN, Pelleg A, Wechsler AS, Kresh JY.

Am J Ther. 2009 May-Jun;16(3):224-30. doi: 10.1097/MJT.0b013e31818be50f.

PMID:
19454861
16.

The first second-generation adenosine drug enters the US market.

Pelleg A, Belardinelli L.

Purinergic Signal. 2008 Dec;4(4):407-8. doi: 10.1007/s11302-008-9114-2. No abstract available.

17.

Anti- and pro-arrhythmic effects of cardiac resynchronization therapy: point of view.

DiPalma JR, Kutalek SP, Eisen H, Kresh JY, Pelleg A.

Am J Ther. 2008 Mar-Apr;15(2):190-5. doi: 10.1097/MJT.0b013e31815adb63.

PMID:
18356643
18.

Cardiac resynchronization therapy in patients with heart failure and left bundle-branch block.

Dipalma JR, Kresh Y, Pelleg A.

Pacing Clin Electrophysiol. 2007 Sep;30(9):1179-80. No abstract available.

PMID:
17725770
19.

The adenosine triphospate (ATP) test for evaluation of syncope of unknown origin.

Flammang D, Pelleg A, Benditt DG.

J Cardiovasc Electrophysiol. 2005 Dec;16(12):1388-9. No abstract available.

PMID:
16403078
20.

Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma.

Basoglu OK, Pelleg A, Essilfie-Quaye S, Brindicci C, Barnes PJ, Kharitonov SA.

Chest. 2005 Oct;128(4):1905-9.

PMID:
16236834
21.

[The adenosine-5'-triphosphate (ATP) test: a diagnostic tool in the management of syncope of unknown origin. Basic and clinical aspects].

Flammang D, Benditt D, Pelleg A.

Ann Cardiol Angeiol (Paris). 2005 Jun;54(3):144-50. Review. French.

PMID:
15991471
22.

Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. V. Role of purinergic receptors.

Xu J, Kussmaul W, Kurnik PB, Al-Ahdav M, Pelleg A.

Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R651-5. Epub 2004 Nov 11.

23.

Adenosine 5'-triphosphate axis in obstructive airway diseases.

Pelleg A, Schulman ES.

Am J Ther. 2002 Sep-Oct;9(5):454-64. Review.

PMID:
12237739
24.

Proarrhythmic effects of adenosine: one decade of clinical data.

Pelleg A, Pennock RS, Kutalek SP.

Am J Ther. 2002 Mar-Apr;9(2):141-7. Review.

PMID:
11897928
25.

Age-dependent atrial remodeling induced by recombinant human interleukin-11: implications for atrial flutter/fibrillation.

Xu J, Ren JF, Mugelli A, Belardinelli L, Keith Jr JC Jr, Pelleg A.

J Cardiovasc Pharmacol. 2002 Mar;39(3):435-40.

PMID:
11862123
26.

Does recombinant human interleukin-11 exert direct electrophysiologic effects on single human atrial myocytes?

Sartiani L, De Paoli P, Lonardo G, Pino R, Conti AA, Cerbai E, Pelleg A, Belardinelli L, Mugelli A.

J Cardiovasc Pharmacol. 2002 Mar;39(3):425-34.

PMID:
11862122
27.

Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.

Mohanty JG, Raible DG, McDermott LJ, Pelleg A, Schulman ES.

J Allergy Clin Immunol. 2001 May;107(5):849-55.

PMID:
11344352
28.

Effect of aging on the negative chronotropic and anti-beta-adrenergic actions of adenosine in the rat heart.

Xu J, Gao F, Ma XL, Gao E, Friedman E, Snyder DL, Horwitz J, Pelleg A.

J Cardiovasc Pharmacol. 1999 Dec;34(6):904-12.

PMID:
10598137
29.

ATP modulates anti-IgE-induced release of histamine from human lung mast cells.

Schulman ES, Glaum MC, Post T, Wang Y, Raible DG, Mohanty J, Butterfield JH, Pelleg A.

Am J Respir Cell Mol Biol. 1999 Mar;20(3):530-7.

PMID:
10030852
30.

Age-related decline in beta adrenergic and adenosine A1 receptor function in the heart are attenuated by dietary restriction.

Gao E, Snyder DL, Roberts J, Friedman E, Cai G, Pelleg A, Horwitz J.

J Pharmacol Exp Ther. 1998 Apr;285(1):186-92.

PMID:
9536009
31.

Effect of aging on A1-adenosine receptor-mediated inhibition of norepinephrine release in the rat heart.

Snyder DL, Wang W, Pelleg A, Friedman E, Horwitz J, Roberts J.

J Cardiovasc Pharmacol. 1998 Mar;31(3):352-8.

PMID:
9514178
32.

Reduced adenosine A1 receptor and G alpha protein coupling in rat ventricular myocardium during aging.

Cai G, Wang HY, Gao E, Horwitz J, Snyder DL, Pelleg A, Roberts J, Friedman E.

Circ Res. 1997 Dec;81(6):1065-71.

PMID:
9400388
33.

Adenosine in the mammalian heart: nothing to get excited about.

Pelleg A, Kutalek SP.

Trends Pharmacol Sci. 1997 Jul;18(7):236-8. Review.

PMID:
9253854
34.

Autonomic neural control of cardiac function: modulation by adenosine and adenosine 5'-triphosphate.

Pelleg A, Katchanov G, Xu J.

Am J Cardiol. 1997 Jun 19;79(12A):11-4. Review.

PMID:
9223357
35.

Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. IV. Role of LV vagal afferents.

Katchanov G, Xu J, Clay A, Pelleg A.

Am J Physiol. 1997 Apr;272(4 Pt 2):H1898-903.

PMID:
9139977
36.

Purinergic modulation of neural control of cardiac function.

Pelleg A, Katchanov G, Xu J.

J Auton Pharmacol. 1996 Dec;16(6):401-5. Review.

PMID:
9131426
37.
38.

Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. III. Role of cardiac afferents.

Katchanov G, Xu J, Hurt CM, Pelleg A.

Am J Physiol. 1996 May;270(5 Pt 2):H1785-90.

PMID:
8928887
39.
40.

ATP shortens atrial action potential duration in the dog: role of adenosine, the vagus nerve, and G protein.

Pelleg A, Hurt CM, Hewlett EL.

Can J Physiol Pharmacol. 1996 Jan;74(1):15-22.

PMID:
8963948
41.

Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals.

Pelleg A, Hurt CM.

J Physiol. 1996 Jan 1;490 ( Pt 1):265-75.

42.

Reproducible induction of EADs and torsade de pointes.

Pelleg A, Hurt CM, Xu J.

Circulation. 1995 Sep 15;92(6):1666-7. No abstract available.

PMID:
7664455
44.

Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine.

Kollias-Baker C, Xu J, Pelleg A, Belardinelli L.

Circ Res. 1994 Dec;75(6):972-80.

PMID:
7955151
45.

Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs. II. Vagal afferent traffic.

Hurt CM, Wang L, Xu J, Sterious W, Pelleg A.

Am J Physiol. 1994 Sep;267(3 Pt 2):H1093-7.

PMID:
8092273
46.

Responsiveness of in situ canine nodose ganglion afferent neurones to epicardial mechanical or chemical stimuli.

Armour JA, Huang MH, Pelleg A, Sylvén C.

Cardiovasc Res. 1994 Aug;28(8):1218-25.

PMID:
7525062
47.
48.

Aggregation of human and canine platelets: modulation by purine nucleotides.

Soslau G, Arabe L, Parker J, Pelleg A.

Thromb Res. 1993 Oct 15;72(2):127-37.

PMID:
8303650
49.

Modulation of in situ canine intrinsic cardiac neuronal activity by locally applied adenosine, ATP, or analogues.

Huang MH, Sylvén C, Pelleg A, Smith FM, Armour JA.

Am J Physiol. 1993 Oct;265(4 Pt 2):R914-22.

PMID:
8238465
50.

Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs.

Pelleg A, Hurt CM, Soler-Baillo JM, Polansky M.

Am J Physiol. 1993 Aug;265(2 Pt 2):H681-90.

PMID:
8368370

Supplemental Content

Loading ...
Support Center